Inhibition of Spontaneous Platelet Aggregation by Sulfinpyrazone

Giuseppe G. Nenci; Giancarlo Agnelli; Mauro Berrettini; Pasquale Parise; Enzo Ballatori

doi:10.1055/s-0038-1666900

Abstract

1 min read

Summary In a randomized double-blind crossover study in 16 patients with enhanced in vitro spontaneous platelet aggregation, sulfinpyrazone proved to be effective in normalizing platelet aggregability within 4 days after initiation of therapy.

Related publications

Article1985

Inhibition of Human Platelet Aggregation by Parathyroid Hormone

Ariela Benigni, M. Livio, P. Dodesini, Arrigo Schieppati, Mario Panigada, G Mecca, Giovanni de Gaetano, Giuseppe Remuzzi

Article1993

Inhibition of Platelet-activating Factor-induced Bronchoconstriction by the Leukotriene D<sub>4</sub>Receptor Antagonist ICI 204,219

Joseph C. Kidney, S M Ridge, Kian Fan Chung, Peter J Barnes

Article1986

Conjugated Estrogens for the Management of Bleeding Associated with Renal Failure

M. Livio, Pier Mannuccio Mannucci, G Viganò, G. Mingardi, Rossana Lombardi, G Mecca, Giuseppe Remuzzi

Article1979

Platelet Lifespan in Pregnancy Complicated by Pre-Eclampsia

Arrigo Schieppati, Marta Cossu, Ermanno Rossi, Giuseppe Remuzzi

Article2018

Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension

N. Bacha, N. Bacha, Marilyne Lévy, Marilyne Lévy, Coralie L. Guérin, Coralie L. Guérin, Bernard Le Bonniec, Bernard Le Bonniec, Annie Harroche, Annie Harroche, Isabelle Szézépanski, Isabelle Szézépanski, Jean Marie Renard, Jean Marie Renard, Pascale Gaussem, Pascale Gaussem, Dominique Israël‐Biet, Dominique Israël‐Biet, Chantal M. Boulanger, Chantal M. Boulanger, David M. Smadja, David M. Smadja